By establishing a potential link between circulating levels of OPN, its expression in microglia, and anti-NMDA production with neuropsychiatric manifestations in lupus models, this research could significantly enhance the accuracy of diagnosis and the potential for early treatment initiation in patients with NPSLE. This evidence concerns the gene SPP1 and systemic lupus erythematosus.